Fhi360 is a global public health and development organization working to improve the lives of the world's most vulnerable people. Established in 1971, Fhi360 is one of the world’s largest and most influential non-profit biomedical research and technical assistance organisations. Fhi360’s work is focused on developing countries, with offices in 47 countries and close to 4400 employees. Through its global reach, Fhi360 is committed to reducing the burden of poverty-related infectious diseases, including Neglected Tropical Diseases. Our success is built on both creating and utilizing data on which to base program activities, as well as strengths in cross-cutting fields of research, monitoring & evaluation (M&E), behaviour change communication & social mobilization, and gender equity.
In 2010, Fhi360 was competitively selected by USAID to execute two projects for control and elimination of seven NTDs in Africa (Ghana, Burkina Faso, Sierra Leone, Togo) and Asia (END in Africa and END in Asia). Diseases covered by END are Lymphatic Filariasis, Onchocerciasis, Schistosomiasis, Trachoma and three Soil-transmitted Helminthes. These two 5-year cooperative agreements were designed to support ministries of health (MOHs) and other government entities as they scale-up integrated control programmes and the delivery of MDA for the same “tool ready” NTDs that are the focus of this proposal. The projects support national NTD programs to implement and scale-up integrated NTD control programmes.
We deliver country-level technical assistance to build capacity within each MOH for rapid scale up and sustained implementation of mass drug administration. During the last three years we have assessed the capacity of M&E systems for NTDs in respective countries, supporting countries in the development of their respective work plans, maximizing opportunities for learning NTD strategies and guidelines, generating program results, and supporting country programs in the monitoring of NTDs.
Fhi360 is a global expert in public health research, with over 40 years’ experience conducting studies in resource-poor settings to strengthen health initiatives. In the realm of implementation research, Fhi360 investigators have worked with programmatic partners throughout sub-Saharan Africa to test the feasibility, effectiveness, fidelity, and cost of alternative health interventions and service delivery strategies. Fhi360 is highly experienced in assessing the information needs and priorities of health care providers, programme implementers, and policy-makers; designing and implementing applied research in collaboration with program managers to improve service delivery; and accelerating the uptake of research findings and inclusion of evidence-based practices into global health policies and programs.
Fhi360 scientists collaborate with programme partners to produce high quality evidence for improving the
quality, effectiveness, reach and efficiency of health services. They resolve programmatic challenges
• Formative assessments to evaluate service delivery contexts and to inform intervention design;
• Operations research to test innovations;
• Implementation research to evaluate the safety and effectiveness of interventions delivered at scale
under typical circumstances;
• Value for Money (V4M) assessments to produce evidence regarding intervention cost-effectiveness
and potential for sustainability.
Through global and local partnerships, Fhi360’s Research Utilization (RU) unit accelerates the uptake of research findings and inclusion of evidence-based practices into global health policies and programmes. Our systematic approach to RU has been applied to a variety of technical areas, including HIV/AIDS, family planning, gender, community-based health systems, mobile technologies for health, integration of health services, and youth-friendly services. Globally, and in Anglophone and Francophone West Africa specifically, Fhi360 has supported the application of evidence in health policy and practice.
Dr Theresa Hoke - COUNTDOWN Research Uptake & Theory of Change Strategist
Dr Hoke is the Director of Health Services Research at Fhi360. Collaborating with partners in resource-poor settings, she conducts implementation research to maximize the effectiveness of public health interventions, with expertise in reproductive health and HIV/AIDS services.
She holds an MPH and a PhD in health policy. With over 20 years of experience conducting applied research to maximize the effectiveness of public health interventions; her area of expertise is implementation research to improve health care provider performance and to expand access to effective primary health care services in sub-Saharan Africa.
In her 15 years at Fhi360 she has led multi-disciplinary teams in conducting a full spectrum of activities supporting programmatic research.
Dr Hoke is adept at supporting host country stakeholders in articulating information needs and translating knowledge gaps into research questions. She further collaborates with national and regional health care managers in conducting research, interpreting findings, and applying results to policy and programming.
She has conducted studies in Uganda, Kenya, South Africa, and Zimbabwe to support development of feasible service delivery strategies for integrating HIV/AIDS and reproductive health services. She has led studies to devise evidence-based approaches for increasing the public health impact of male and female condom programming on control of sexually transmitted infection.
Dr. Hoke has also conducted operations research to test the feasibility, acceptability, and effectiveness of family planning service delivery innovations. Her research on provision of injectable contraceptives by community health workers in Madagascar and on provision of inter-uterine contraceptive device services to postpartum women in Rwanda produced evidence supporting national scale-up of those services.